Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Intervention1: Acetyl-L carnitine, Palmitoyl Ethanolamide, Vitamin-B12: Acetyl-L carnitine 500mg OD po for 3months, Palmitoyl Ethanolamide 300mg OD for 3months, vitamin-B12 1500mcg OD po for 3months
I
Sponsors
Saveetha Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient diagnosed with Type-2 diabetes mellitus for more than a year 2.HbA1c of more than 5.9% 3.Patients experiencing moderate to severe neuropathic pain assessed by Visual Analogue Score(VAS) for pain 4.Abnormal nerve conduction velocity and amplitude in at least one of the nerve extremities.
Exclusion criteria
Exclusion criteria: 1.Patients with neuropathy due to other causes other than diabetes mellitus 2.History of alcohol or use of any other illicit drugs 3.Pregnant and lactating women 4.Participation in another clinical trial that might interfere with this study’s result
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in neuropathic pain measured by Visual Analogue Score(VAS) and improvement in nerve conduction velocityTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life and assessing the rate of clinical adverse reactionsTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr.Yohidha Balamurugan
Saveetha Medical College and Hospital
Outcome results
None listed